Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guodong He

Showing results (51-60 of 89) with videos related to

Pageof 9
Sort By:
Cell Discovery|May 13, 2026
A negative survival pressure selection system enables GPCR antagonist screeningTao Xu, Qinxin Sun, Shuhao Zhang, et al.
Oncotarget|April 16, 2016
Silencing homeobox C6 inhibits colorectal cancer cell proliferationMeiling Ji, Qingyang Feng, Guodong He, et al.
Cell|January 28, 2026
A GPCR-G protein-β-arrestin megacomplex enabled by a versatile allosteric modulatorGuodong He, Qinxin Sun, Xinyu Xu, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 23, 2014
Rapid determination of fenoldopam in human plasma by UPLC-MS/MS for pharmacokinetic analysis in patientsXipei Wang, Zhijie Zheng, Guodong He, et al.
International Journal of Oncology|February 6, 2016
Ribosomal protein S15A promotes malignant transformation and predicts poor outcome in colorectal cancer through misregulation of p53 signaling pathwayJingwen Chen, Ye Wei, Qingyang Feng, et al.
Advanced Healthcare Materials|September 3, 2025
Pain-Free and Wireless Luminescent Microneedle Sensor Array for In Situ Monitoring Tissue Oxygenation Status in Diabetic Foot UlcersRui Jiang, Ying Xu, En-Lai Yang, et al.
Journal of Translational Medicine|June 14, 2020
A novel patient-derived organoids-based xenografts model for preclinical drug response testing in patients with colorectal liver metastasesMi Jian, Li Ren, Guodong He, et al.
Cancer Management and Research|September 15, 2018
Differences in clinical characteristics and mutational pattern between synchronous and metachronous colorectal liver metastasesPeng Zheng, Li Ren, Qingyang Feng, et al.
Clinical Medicine Insights. Oncology|March 28, 2022
No.253 Lymph Nodes Metastasis in Left-Sided Colorectal Cancer Liver Metastasis (CRLM) Patients: Incidence and PrognosisJiang Chang, Yihao Mao, Qingyang Feng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2020
Bevacizumab Plus mFOLFOX6 Versus mFOLFOX6 Alone as First-Line Treatment for <i>RAS</i> Mutant Unresectable Colorectal Liver-Limited Metastases: The BECOME Randomized Controlled TrialWentao Tang, Li Ren, Tianshu Liu, et al.
Pageof 9

Showing results (51-60 of 89) with videos related to

Sort By:
Pageof 9
Cell Discovery|May 13, 2026
A negative survival pressure selection system enables GPCR antagonist screeningTao Xu, Qinxin Sun, Shuhao Zhang, et al.
Oncotarget|April 16, 2016
Silencing homeobox C6 inhibits colorectal cancer cell proliferationMeiling Ji, Qingyang Feng, Guodong He, et al.
Cell|January 28, 2026
A GPCR-G protein-β-arrestin megacomplex enabled by a versatile allosteric modulatorGuodong He, Qinxin Sun, Xinyu Xu, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 23, 2014
Rapid determination of fenoldopam in human plasma by UPLC-MS/MS for pharmacokinetic analysis in patientsXipei Wang, Zhijie Zheng, Guodong He, et al.
International Journal of Oncology|February 6, 2016
Ribosomal protein S15A promotes malignant transformation and predicts poor outcome in colorectal cancer through misregulation of p53 signaling pathwayJingwen Chen, Ye Wei, Qingyang Feng, et al.
Advanced Healthcare Materials|September 3, 2025
Pain-Free and Wireless Luminescent Microneedle Sensor Array for In Situ Monitoring Tissue Oxygenation Status in Diabetic Foot UlcersRui Jiang, Ying Xu, En-Lai Yang, et al.
Journal of Translational Medicine|June 14, 2020
A novel patient-derived organoids-based xenografts model for preclinical drug response testing in patients with colorectal liver metastasesMi Jian, Li Ren, Guodong He, et al.
Cancer Management and Research|September 15, 2018
Differences in clinical characteristics and mutational pattern between synchronous and metachronous colorectal liver metastasesPeng Zheng, Li Ren, Qingyang Feng, et al.
Clinical Medicine Insights. Oncology|March 28, 2022
No.253 Lymph Nodes Metastasis in Left-Sided Colorectal Cancer Liver Metastasis (CRLM) Patients: Incidence and PrognosisJiang Chang, Yihao Mao, Qingyang Feng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2020
Bevacizumab Plus mFOLFOX6 Versus mFOLFOX6 Alone as First-Line Treatment for <i>RAS</i> Mutant Unresectable Colorectal Liver-Limited Metastases: The BECOME Randomized Controlled TrialWentao Tang, Li Ren, Tianshu Liu, et al.
Pageof 9